Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Lebrikizumab for Allergic Rhinitis
Recruiting1 awardPhase 3
Cincinnati, Ohio
"This trial aims to test if lebrikizumab is effective and safe for adults with year-round allergic rhinitis. The study will take around 13 months to complete."
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.